Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
US6207170A · kind A · utility
2Cited by
4References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 1999 |
| Grant date | Mar 27, 2001 |
| Priority date | — |
| Expiry date | Jan 15, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55572
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Membrane-proteoliposome structures (MPs) are useful in preparing patient-specific vaccines against specific white blood cell (WBC) malignancies. The inventive MPs typically contain a membrane component derived from a specific WBC. Other useful components include immunostimulators and exogenous lipids. The resulting vaccines are both patient- and malignancy-specific.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.